Metrikler
Yayın
55
Açık Erişim
2
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1987 - 1992
1987 - 1992Tıpta Uzmanlık
Ege Üniversitesi, Tıp Fakültesi, Nöroloji, Türkiye
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
Nöroloji
Makaleler
Tümü (31)
SCI-E, SSCI, AHCI (27)
SCI-E, SSCI, AHCI, ESCI (31)
ESCI (4)
Scopus (29)
TRDizin (5)
2025
20251. Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort
Samadzadeh S., Oertel F. C., Salih H., Lin T., Motamedi S., Chien C., et al.
European Journal of Neurology
, cilt.32, sa.6, 2025 (SCI-Expanded)
2025
20252. The Effect of Smoking and Passive Exposure on Multiple Sclerosis and Correlation with IL17 & IL23 Levels Multipl skleroz hastalarında tütün tüketiminin hastalık sürecine etkisi ve IL-17 ile IL-23 düzeylerinin korelasyonu
ELMALI YAZICI A. D., Oral G., ORHAN N., Altintaş A.
Noropsikiyatri Arsivi
, cilt.62, sa.1, ss.54-61, 2025 (SCI-Expanded)
2024
20243. Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study Cohort
Chien C., Cruz E Silva V., Geiter E., Meier D., Zimmermann H., Bichuetti D. B., et al.
Radiology
, cilt.313, sa.2, 2024 (SCI-Expanded)
2022
20224. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
Sen S., Tuncer A., ÖZAKBAŞ S., Uzunkopru C., Baba C., Demir S., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.58, 2022 (SCI-Expanded)
2022
20225. Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders
Lu A., Zimmermann H. G., Specovius S., Motamedi S., Chien C., Bereuter C., et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
, cilt.93, ss.188-195, 2022 (SCI-Expanded)
2022
20226. Temperament and character in relapsing-remitting multiple sclerosis: association with clinical factors and psychiatric disorders
KILIÇ Ö., Celik R. G. G., Emul M., SAİP S., Altintas A., Siva A.
CUKUROVA MEDICAL JOURNAL
, cilt.47, sa.3, ss.1339-1349, 2022 (ESCI)
2021
20217. Retinal Optical Coherence Tomography in Neuromyelitis Optica
Oertel F. C., Specovius S., Zimmermann H. G., Chien C., Motamedi S., Bereuter C., et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
, cilt.8, sa.6, 2021 (SCI-Expanded)
2021
20218. The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice
Vural A., Simsir G., Tekgul S., Kocoglu C., Akcimen F., Kartal E., et al.
MOVEMENT DISORDERS
, cilt.36, ss.1676-1688, 2021 (SCI-Expanded)
2020
20209. Risk of secondary progressive multiple sclerosis: A longitudinal study
Fambiatos A., Jokubaitis V., Horakova D., Havrdova E. K., Trojano M., Prat A., et al.
MULTIPLE SCLEROSIS JOURNAL
, cilt.26, sa.1, ss.79-90, 2020 (SCI-Expanded)
2020
202010. Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO)
Specovius S., Zimmermann H. G., Oertel F. C., Chien C., Bereuter C., Cook L. J., et al.
BMJ OPEN
, cilt.10, sa.10, 2020 (SCI-Expanded)
2019
201911. Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD
Cook L. J., Rose J. W., Alvey J. S., Jolley A. M., Kuhn R., Marron B., et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
, cilt.6, sa.5, 2019 (SCI-Expanded)
2018
201812. Factors Predictive of Severe Multiple Sclerosis Disease Reactivation After Fingolimod Cessation
Uygunoglu U., Tutuncu M., Altintas A., Saip S., Siva A.
NEUROLOGIST
, cilt.23, sa.1, ss.12-16, 2018 (SCI-Expanded)
2017
201713. Cytokine Polymorphism and HLA Genotyping in Patients with Temporal Lobe Epilepsy Related to Hippocampal Sclerosis
Altintas A., Ozkara C., Sevindik M. S., Uzan M., Cinar Ç., UYSAL Ö., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.54, sa.4, ss.350-353, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
201714. Catastrophic presentation of a patient with combined NMOSD and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a case report
Okhovat A. A., Ansari B., Rezaali S., Altintas A., Moghadasi A. N.
ACTA NEUROLOGICA BELGICA
, cilt.117, sa.3, ss.757-759, 2017 (SCI-Expanded)
2017
201715. Identification of 3 Novel Patients with CLCN2-Related Leukoencephalopathy due to CLCN2 Mutations
Zeydan B., Uygunoglu U., Altintas A., Saip S., Siva A., Abbink T. E., et al.
European Neurology
, cilt.78, ss.125-127, 2017 (SCI-Expanded)
2017
201716. Next generation sequencing analysis of patients with familial cervical artery dissection
Grond-Ginsbach C., Brandt T., Kloss M., Aksay S. S., Lyrer P., Traenka C., et al.
EUROPEAN STROKE JOURNAL
, cilt.2, sa.2, ss.137-143, 2017 (ESCI)
2016
201617. NMOSD with an unusual cerebral radiologic manifestation
Moghadasi A. N., Altintas A.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, cilt.7, ss.74-75, 2016 (SCI-Expanded)
2016
201618. Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome
Disanto G., Adiutori R., Dobson R., Martinelli V., Costa G. D., Runia T., et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
, cilt.87, sa.2, ss.126-129, 2016 (SCI-Expanded)
2016
201619. Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks
Alroughani R., Altintas A., Al Jumah M., Sahraian M., Alsharoqi I., AlTahan A., et al.
MULTIPLE SCLEROSIS INTERNATIONAL
, 2016 (ESCI)
2016
201620. Sciatic neuropathy developed after injection during curettage
Altintas A., Gunduz A., Kantarci F., Gozubatik Celik G., Kocer N., Kiziltan M. E.
AGRI-THE JOURNAL OF THE TURKISH SOCIETY OF ALGOLOGY
, cilt.28, sa.1, ss.46-48, 2016 (ESCI)
2015
201521. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort Demographic, Clinical, and Laboratory Features
Altintas A., KARABUDAK R., Balci B. P., TERZİ M., Soysal A., Saip S., et al.
NEUROLOGIST
, cilt.20, sa.4, ss.61-66, 2015 (SCI-Expanded)
2015
201522. Pregnancy Data in a Turkish Multiple Sclerosis Population
Altintas A., Najar B., Gozubatik-Celik G., Menku S. F.
EUROPEAN NEUROLOGY
, cilt.74, ss.296-302, 2015 (SCI-Expanded)
2014
201423. Familial occurrence and heritable connective tissue disorders in cervical artery dissection
Debette S., Simonetti B. G., Schilling S., Jose Martin J., Kloss M., Sarikaya H., et al.
NEUROLOGY
, cilt.83, sa.22, ss.2023-2031, 2014 (SCI-Expanded)
2014
201424. Cases of Narcolepsy-Cataplexy Syndrome Following H1N1 Vaccination
Nalbantoglu M., Benbir G., Karadeniz D., Altintas A., Oguz F.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.51, sa.3, ss.283-287, 2014 (SCI-Expanded)
2013
201325. Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
Teunissen C., Menge T., Altintas A., Alvarez-Cermeno J. C., Bertolotto A., Berven F. S., et al.
MULTIPLE SCLEROSIS JOURNAL
, cilt.19, sa.13, ss.1802-1809, 2013 (SCI-Expanded)
2013
201326. Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy
Seven A., Aslan M., Incir S., Altintas A.
FOLIA NEUROPATHOLOGICA
, cilt.51, sa.1, ss.58-64, 2013 (SCI-Expanded)
2012
201227. Magnetic resonance imaging of rheumatoid meningitis: a case report and literature review
Hasiloglu Z. I., Asik M., Erer B., Dikici A. S., Altintas A., Albayram S.
RHEUMATOLOGY INTERNATIONAL
, cilt.32, sa.11, ss.3679-3681, 2012 (SCI-Expanded)
2011
201128. Pathological Contrast Enhancement of the Oculomotor and Trigeminal Nerves Caused by Intracranial Hypotension Syndrome
Albayram S., Asik M., Hasiloglu Z. I., Dikici A. S., Erdemli H. E., Altintas A.
HEADACHE
, cilt.51, sa.5, ss.804-808, 2011 (SCI-Expanded)
2008
200829. Immunological abnormalities in the patients with autistic regression
Altintas A., Korkmaz B., Poyraz C. A., Ozdemir S., Oguz F., Kekik C., et al.
JOURNAL OF NEUROIMMUNOLOGY
, cilt.203, sa.2, ss.192, 2008 (SCI-Expanded)
2008
200830. GROUP EXERCISE TRAINING APPROACH TO MULTIPLE SCLEROSIS REHABILITATION
Mutluay F. K., Tekeoglu A., Saip S., Altintas A., Siva A.
NOBEL MEDICUS
, cilt.4, sa.3, ss.20-26, 2008 (SCI-Expanded)
2007
200731. Pulmonary function in multiple sclerosis without any respiratory complaints
Altintas A., Demir T., Ikitimur H. D., Yildirim N.
CLINICAL NEUROLOGY AND NEUROSURGERY
, cilt.109, sa.3, ss.242-246, 2007 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2018
20181. Multipl Skleroz Patogenezinde CD3(-) CD16 ()CD 56 NK Hücrelerinin Fonksiyonel Analizi
TAHRALI İ., KÜÇÜKSEZER U. C., ALTINTAŞ A., UYGUNOĞLU U., DENİZ G.
İmmünolojide Moleküller Sempozyumu, İzmir, Türkiye, 18 Ekim 2018 - 21 Ekim 0018, ss.1, (Tam Metin Bildiri)
2018
20182. Increased IL-22 levels in relapsing - remitting Multiple Sclerosis
TAHRALI İ., KÜÇÜKSEZER U. C., AKDENİZ N., ALTINTAŞ A., UYGUNOĞLU U., ÇETİN E., et al.
Abstracts of the 5th European Congress of Immunology-ECI 2018, Amsterdam, Hollanda, 2 - 05 Eylül 2018, cilt.P.C6.06.19, ss.429, (Tam Metin Bildiri)
2018
20183. Presentation of Neuromyelitis Optica (NMO) in patients from different racial groups: analysis of the global NMOBase Registry
Kister I., Bacon T., Shaygannejad V., Havrdova E., Alroughani R., TERZİ M., et al.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)
2018
20184. Does Co-morbidity with Familial Mediterranean Fever change the course of Multiple Sclerosis?
Siva A., Tutuncu M., Uygunoglu U., Erdogan M., Ugurlu S., Ozcan B., et al.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90
2016
20165. How to Differentiate Longitudinally Extensive Transverse Myelitis of Neuro-Behcet Syndrome from Neuromyelitis Optica Spectrum Disorders?
Siva A., Uygunoglu U., Zeydan B., Tutuncu M., Ozguler Y., Seyahi E., et al.
9th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Bangkok, Tayland, 27 - 29 Ekim 2016, cilt.23, ss.342, (Özet Bildiri)
2016
20166. The increased IL-22 levels in relapsing-remitting multiple sclerosis.
TAHRALI İ., AKDENİZ N., KÜÇÜKSEZER U. C., Aydın B., UYGUNOĞLU U., ALTINTAŞ A., et al.
3rd International Molecular Immunology & Immunogenetics Congress (MIMIC III), Antalya, Türkiye, 27 - 30 Nisan 2016, cilt.4, sa.1, ss.78, (Tam Metin Bildiri)
2016
20167. Rebound of Disease Activity after Fingolimod Discontinuation: Report of Six Cases
Siva A., Uygunoglu U., Tutuncu M., Altintas A., Saip S.
68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri)
2015
20158. Multipl Skleroz hastalarında CD16+CD56soluk ve CD16-CD56parlak NK hücrelerinin farklı sitokin uyarımlarına geç yanıtları
TAHRALI İ., KÜÇÜKSEZER U. C., AKDENİZ N., ÇETİN E., Adaş Ç. U., UYGUNOĞLU U., et al.
23. Ulusal İmmünoloji Kongresi, Antalya, Türkiye, 26 - 30 Nisan 2015, ss.104, (Tam Metin Bildiri)
2014
20149. CLIPPERS syndrome: Case report
Altintas A., Alpaslan B. G., Uygunoglu U.
12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.95
2014
201410. Assessment of aquaporin-4 (AQP4) antibody assays in European diagnostic centres
Waters P., Reindl M., Schanda K., Tuller F., Kral V., Nytrova P., et al.
12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.15, (Özet Bildiri)
2014
201411. Natural killer cells have immune regulatory effects in Multiple Sclerosis
TAHRALI İ., KÜÇÜKSEZER U. C., ÇETİN E., AKDENİZ N., Adaş Ç. U., Yılmaz A., et al.
XXIX Congress of the International Society for Advancement of Cytometry (CYTO 2014), Fort Lauderdale, Amerika Birleşik Devletleri, 17 - 21 Mayıs 2014, ss.172, (Tam Metin Bildiri)
2014
201412. Natural Killer Cells: Do they have any immune regulatory effects in Multiple Sclerosis?
Tahralı İ., Küçüksezer U. C., Aktas E., Akdeniz N., Yılmaz A., Adaş C. U., et al.
World Immune Regulation Meeting VIII, 19-22 March 2014,, Chur, İsviçre, 19 - 22 Mart 2014, ss.44, (Tam Metin Bildiri)
2013
201313. Multiple Skleroz hastalarında Doğal Öldürücü (NK) Hücre Sitokin içerikleri ve Sitotoksik Yanıtlar.
Tahralı İ., Küçüksezer U. C., Akdeniz N., Çetin E., Yılmaz A., Altıntaş A., et al.
22. Ulusal İmmünoloji Kongresi, Antalya, Türkiye, 27 - 30 Nisan 2013, ss.30, (Tam Metin Bildiri)
2013
201314. Characterization of NMO and NMOSD Patients with a Late Onset
Collongues N., Marignier R., Jacob A., Siva A., Paul F., Zephir H., et al.
65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 16 - 23 Mart 2013, cilt.80
2012
201215. The frequency of inflammatory activity (intrathecal oligoclonal bands and Gd-enhancement in MRI) in German and Turkish MS cases
Tumani H., Altintas A., Nalbantoglu M., Zeydan B., Roesler R., Brettschneider J.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.23, (Özet Bildiri)
2012
201216. Immunoregulatory role of Natural killer cells in Multiple Sclerosis
Altintas A., Uygunoglu U., Tahrali I., Kucuksezer U. C., Yilmaz A., Deniz G.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.36, (Özet Bildiri)
2012
201217. NMO-spectrum disorders in Turkish population: Clinical, demographic characteristics and the presence of NMO-Ig G
Altintas A., Soysal A., TERZİ M., Isik N., Duman T., Gozubatik-Celik G., et al.
11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.27, (Özet Bildiri)
2010
201018. Kognitif tutulum olan multipl skleroz hastalarında ne yapmalı? Bilgisayar destekli kognitif rehabilitasyon bir tedavi seçeneği olabilir mi?
Topçular B., Bingöl A., Yildiz S., Guclu I., KUŞÇU D. Y., Soysal A., et al.
46. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 4 - 09 Aralık 2010, ss.1, (Tam Metin Bildiri)
2010
201019. What to do in multiple sclerosis patients with cognitive involvement? Computer-assisted cognitive rehabilitation: is it a treatment option?
Topçular B., Bingöl A., Yildiz S., Guclu I., KUŞÇU D. Y., Soysal A., et al.
26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis and 15th Annual Conference of Rehabilitation in Multiple Sclerosis, Göteborg, İsveç, 13 - 16 Ekim 2010, ss.76, (Tam Metin Bildiri)
2007
200720. The role of Chlamydia pneumonia and human herpes virus 6 in aetiopathogenesis of multiple sclerosis and the relation of multiple sclerosis with apolipoprotein E genotypes
KOCAZEYBEK B., KARATOKA B., ASLAN M., SARIBAS S., ALTINTAŞ A., ERGİN S., et al.
17th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases), Münih, Almanya, 31 Mart - 03 Nisan 2007, cilt.29, sa.2, ss.234, (Tam Metin Bildiri)
2000
200021. Prevalence of serum antibodies to hepatitis C virus in patients with multiple sclerosis.
MERT A., Altıntaş A., BİLİR M., ÖZARAS R., TABAK Ö. F., ÖZTÜRK R., et al.
10th European Congress of Clinical Microbiology and Infectious Diseases., Stokholm, İsveç, 28 - 31 Mayıs 2000, cilt.6, ss.151, (Tam Metin Bildiri)
Kitaplar
2013
20131. Multipl Skleroz: Patolojik Özellikler
ALTINTAŞ A., YAZICI AKKAŞ S., ELMALI YAZICI A. D.
Temel ve Klinik Nöroimmünoloji, Karabudak R, Editör, Ada Basın Yayın Ltd. Şti., Ankara, ss.205-222, 2013
2013
20132. Multipl Sklerozda İmmünsüpresif ve Diğer Tedaviler
ALTINTAŞ A., Yandım Kuşçu D., Akman Demir G., ELMALI YAZICI A. D.
Multipl Sklerozda tanı ve tedavi kılavuzu, İdiman E, Karabudak R, Işık N, Siva A., Editör, Galenos Yayınevi, İstanbul, ss.40-56, 2013
Diğer Yayınlar
1998
19981. Neuropsychological correlates of Multiple Sclerosis
Tekdemir Yurtdaş G., Altıntaş A., Siva A., Townes B. D.
Diğer, ss.22, 1998
Desteklenen Projeler
2013 - 2014
2013 - 2014Klinik İzole Sendrom'da kan ve beyin omurilik sıvısında biyolojik belirteçler: Fetuin A, S100B ve GFAP
Yükseköğretim Kurumları Destekli Proje , BAP Doktora
ALTINTAŞ A. (Yürütücü)